Wyeth

American Home ProductsWyeth PharmaceuticalsA.H. RobinsLederle LaboratoriesWyeth LaboratoriesA. H. Robins CompanyA.H. Robins PharmaceuticalsAdvilAmerican FoodsAmerican Home Foods
Wyeth was a pharmaceutical company purchased by Pfizer in 2009.wikipedia
369 Related Articles

Pfizer

Pfizer Inc.Warner-LambertPfizer Inc
Wyeth was a pharmaceutical company purchased by Pfizer in 2009.
In this decade, Pfizer grew by mergers, including those with Warner–Lambert (2000), Pharmacia (2003), and Wyeth (2009).

Conjugated estrogens

conjugated equine estrogenconjugated estrogenPMU
Wyeth manufactured over-the-counter (OTC) drugs Robitussin and the analgesic Advil (ibuprofen) as well as prescription drugs Premarin and Effexor. With this merger came Premarin, the world's first conjugated estrogen medicine, which was a flagship product for AHP until 2002, when preliminary results from the Women's Health Initiative linked it to a number of negative effects, including increased risk for breast cancer.
Premarin, the major brand of CEEs in use, is manufactured by Wyeth and was first marketed in 1941 in Canada and in 1942 in the United States.

Anacin

In 1930, Wyeth purchased Anacin, a product for tension headaches which quickly became the company's flagship product.
Since 1930 it is being manufactured by Wyeth, now Pfizer.

George Washington (inventor)

George Washington
In 1943, Wyeth purchased G. Washington Coffee Refining Company, an instant coffee company created by George Washington.
Washington's company was sold to American Home Products in 1943, shortly before his death.

Pharmaceutical industry

pharmaceutical companypharmaceuticalpharmaceutical companies
Wyeth was a pharmaceutical company purchased by Pfizer in 2009.

Women's Health Initiative

NIH Women's Health InitiativeWHIWomen's Health Initiative Calcium/Vitamin D Supplementation Study
With this merger came Premarin, the world's first conjugated estrogen medicine, which was a flagship product for AHP until 2002, when preliminary results from the Women's Health Initiative linked it to a number of negative effects, including increased risk for breast cancer.
Women assigned to the intervention group who had previously undergone a hysterectomy were treated with unopposed estrogen, specifically conjugated estrogens (Premarin), manufactured by (Wyeth), at a dosage of 0.625 mg/day ("E-alone," n = 5310; placebo, n = 5429).

Dalkon Shield

In negotiations that lasted from 1986 to 1989, AHP acquired A.H. Robins which had been driven into bankruptcy by litigation over Dalkon Shield, and which also sold Reglan, Robitussin, ChapStick, and Dimetapp, and merging it into its Whitehall unit to establish its Whitehall-Robins Division.
The Dalkon Shield was a contraceptive intrauterine device (IUD) developed by the Dalkon Corporation and marketed by the A.H. Robins Company.

Dimetapp

In negotiations that lasted from 1986 to 1989, AHP acquired A.H. Robins which had been driven into bankruptcy by litigation over Dalkon Shield, and which also sold Reglan, Robitussin, ChapStick, and Dimetapp, and merging it into its Whitehall unit to establish its Whitehall-Robins Division.
Dimetapp is a brand of over-the-counter cold and allergy medicines manufactured by Pfizer (formerly Wyeth).

ChapStick

Chap Stick
In negotiations that lasted from 1986 to 1989, AHP acquired A.H. Robins which had been driven into bankruptcy by litigation over Dalkon Shield, and which also sold Reglan, Robitussin, ChapStick, and Dimetapp, and merging it into its Whitehall unit to establish its Whitehall-Robins Division.
AHP later changed its name to Wyeth.

Genetics Institute

AHP also acquired full ownership of Genetics Institute, Inc. after acquiring a majority interest in 1992.
For that successor company, see Wyeth.''

Centrum (multivitamin)

Centrum
This acquisition brought the Lederle Praxis vaccines, new research and development capacity, and Centrum, the leading US multivitamin.
Centrum is a brand of multivitamins produced by Pfizer (formerly Wyeth).

Reckitt Benckiser

Reckitt & ColmanReckitt and ColmanBenckiser
In 1990, Reckitt & Colman (now Reckitt Benckiser) acquired Boyle-Midway from American Home Products.
In 1938 Reckitt & Sons merged with J. & J. Colman, which had been founded in 1814 when Jeremiah Colman began milling flour and mustard in Norwich, England, to become Reckitt & Colman Ltd. The company made several acquisitions, including the Airwick and Carpet Fresh brands (1985), the Boyle-Midway division of American Home Products (1990), and the Lehn & Fink division of Sterling Drug (1994).

Chef Boyardee

Beef-A-RoniChef Boy-R-Dead
Under Brush's leadership, 34 new companies were acquired in 15 years, including Chef Boyardee and the S.M.A. Corporation, a pharmaceutical firm specializing in infant formulas.
After the war, instead of reducing production, the company was sold to American Home Products in 1946 so that everyone working there would be able to keep their jobs.

Serotonin–norepinephrine reuptake inhibitor

serotonin-norepinephrine reuptake inhibitorSNRIserotonin-norepinephrine reuptake inhibitors
Effexor (venlafaxine HCl), the first serotonin-noradrenaline reuptake inhibitor (SNRI), is introduced for the treatment of clinical depression and is later indicated for generalized anxiety disorder and social anxiety disorder.
Venlafaxine—the first and most commonly used SNRI. It was introduced by Wyeth in 1994. The reuptake effects of venlafaxine are dose-dependent. At low doses (150 mg/day), it acts on serotonergic and noradrenergic systems, whereas at high doses (>300 mg/day), it also affects dopaminergic neurotransmission.

PAM (cooking oil)

PAM
After a dedication of the food business, the PAM trademark becomes part of American Home Foods.
The name PAM is an acronym for Product of Arthur Meyerhoff. In 1971, Gilbraltar Industries merged with American Home Products (now Wyeth) and became part of the Boyle-Midway portfolio.

Primidone

The anticonvulsant Mysoline was introduced in 1954.
Primidone was introduced in 1954 under the brandname Mysoline by Wyeth in the United States.

Bioidentical hormone replacement therapy

bioidenticalbioidentical hormone therapyand her team of doctors
Wyeth, as a corporation, filed a "citizens' complaint" with the US FDA on October 16, 2005, requesting that the FDA take action against pharmacies who compound, manufacture, or sell unlicensed Bioidentical hormone replacement therapy (BHRT) drugs to their patients.
It was supplanted on the market when its manufacturer, Ayerst (later Wyeth Pharmaceuticals), began producing the more easily manufactured conjugated equine estrogens in 1941 under the brand name Premarin; by 1992, Premarin was the most widely prescribed drug in the United States.

Robert R. Ruffolo Jr.

Robert Ruffolo
Wyeth's research and development director Robert Ruffolo was quoted in The New York Times about the firm's efforts to develop new drugs.
Robert R. Ruffolo (born April, 1950, in Yonkers, N.Y.) was president of research and development for Wyeth Pharmaceuticals, and corporate senior vice president of Wyeth from 2001 to 2008.

Promethazine

phenerganPhensedylPrometh
In 1951, AHP launched Antabuse, a drug for the treatment of alcoholism, as well as the antihistamine Phenergan.
Diana Levine, a woman suffering from a migraine, was administered Wyeth's Phenergan via IV push.

Sirolimus

rapamycin
A "whistleblower suit" was filed against Wyeth in 2005 alleging that the company illegally marketed their drug Rapamune.
It was approved by the US Food and Drug Administration in September 1999 and is marketed under the trade name Rapamune by Pfizer (formerly by Wyeth).

Fenfluramine/phentermine

fen-phenin combination with phenterminePhen-fen
In 1997, the U.S. Food and Drug Administration (FDA) requested that AHP withdraw its controversial diet drug fenfluramine from the market by after several reports of deaths and other health problems associated with the drug combination known as fen-phen occurred.
Fenfluramine was marketed by American Home Products (later known as Wyeth) as Pondimin, but was shown to cause potentially fatal pulmonary hypertension and heart valve problems, which eventually led to its withdrawal and legal damages of over $13 billion.

Pneumococcal conjugate vaccine

PCVPrevnar13vPCV
On July 1, 2006, Wyeth launched Prevnar — its international vaccine for Invasive Pneumococcal Disease (IPD) — in India.
Prevnar (PCV7) is a heptavalent vaccine, meaning that it contains the cell capsule sugars of seven serotypes of the bacteria S. pneumoniae (4, 6B, 9V, 14, 18C, 19F and 23F), conjugated with diphtheria proteins. It was manufactured by Wyeth (which has since been acquired by Pfizer). In the United States, vaccination with Prevnar is recommended for all children younger than 2 years, and for unvaccinated children between 24 and 59 months old who are at high risk for pneumococcal infections.

American Cyanamid

American Cyanamid CompanyLederleLederle Laboratories
In 1994, AHP acquired American Cyanamid and its subsidiary Lederle Laboratories.
The company merged with American Home Products (AHP) in 1994.

Slaymaker lock company

Baldwin
He completed the divestiture of non-core businesses such as household products (for example the Slaymaker lock company), foods, candy (Brach's Candy), and medical devices (e.g., its Sherwood-Medical Company was sold to Tyco-Kendal in 1997).
In 1973 the Slaymaker Lock Company was sold to the American Home Products Corporation and made part of Ecko Housewares Division.

Metoclopramide

metaclopromidemetoclopramide hydrochloridemetoclopromide
In negotiations that lasted from 1986 to 1989, AHP acquired A.H. Robins which had been driven into bankruptcy by litigation over Dalkon Shield, and which also sold Reglan, Robitussin, ChapStick, and Dimetapp, and merging it into its Whitehall unit to establish its Whitehall-Robins Division.
in 1989 A.H. Robins was acquired by American Home Products, which changed its name to Wyeth in 2002.